Skip to main content

Sophia Linton

Mon, 01/13/2020 - 14:17

Way to go, Marty, that was a great summary!

The reality is that global funding for HIV research is diminishing, and researchers are dividing themselves into two "camps" concerning how best to allocate that funding.

A) Discover A CURE, no matter how involved or expensive (e.g., CAR-T therapy).

B) Discover ONLY a cure that is explicitly targetted to developing countries (e.g., vaccine-based)

While both options are great examples of translational research, which "camp" do people think should receive the most funding?

Sophia Linton

Plain text

  • No HTML tags allowed.
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.